Search Results (1,728)

Iron supplementation in patients with tuberculosis remains a controversial issue due to the complex role of iron in the host immune response and in the pathogenesis of Mycobacterium tuberculosis infection. Although supplementation may be beneficial for some patients with persistent iron deficiency, the available evidence does not support its routine use. The efficacy and safety of such an intervention appear to depend, among other factors, on the activity of the inflammatory process, the severity of iron metabolism disturbances, and the timing of supplementation initiation. Current evidence highlights the need for an individualized assessment of iron status and for further research to establish clear clinical recommendations. At the same time, growing interest has been directed toward the role of long-chain omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as potential modulators of immune and inflammatory responses in tuberculosis. EPA and DHA may influence immune cell function, cytokine production, and the formation of lipid mediators involved in the resolution of inflammation. Experimental evidence suggests that omega-3 fatty acids may reduce the severity of inflammation and infection-associated anemia; however, their effectiveness may depend on baseline fatty acid status, the stage of disease, and interactions with other nutrients, including iron. Human clinical evidence remains very limited and is currently based mainly on one small intervention study, therefore, clinical claims regarding omega-3 fatty acids supplementation should be interpreted cautiously and should not be understood as a recommendation for routine use. The aim of this review is to discuss the significance of iron metabolism and omega-3 fatty acids in tuberculosis, with particular emphasis on their roles in the regulation of inflammation, immune responses, anemia, and potential nutritional support. Current evidence underscores the need for individualized nutritional interventions and further clinical research to determine the safety, efficacy, and optimal timing of iron and omega-3 fatty acids supplementation in patients with tuberculosis. Full article

Omega-3-fortified foods sit at the interface of lipid science, food technology, and prevention-oriented nutrition. The aim of this narrative review is to define practical criteria for evaluating whether fortified foods can deliver physiologically relevant eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) rather than merely declare omega-3 addition. This review focuses on fish oils, fish-processing by-product oils, single-cell oils, and encapsulated or emulsified delivery systems used in dairy products, bakery products, beverages, spreads, eggs, infant and maternal foods, nutrition bars, and related functional foods. It integrates evidence on raw material composition, refining, oxidative stability, food-matrix compatibility, retained dose during shelf life, bioavailability, biomarker response, health benefits, safety concerns, and regulatory communication. The proposed source-to-status quality-by-design framework emphasizes that applied value depends on traceable source selection, analytical quality control, matrix-specific protection, end-of-shelf-life verification, transparent dose labeling, and claims that remain proportional to evidence. Ordinary low-dose fortified foods should not be presented as equivalents of prescription omega-3 products or as general disease-prevention tools. Their defensible role is status-oriented dietary optimization in populations with low EPA/DHA intake. Full article

Background/Objectives: Discrimination between iron deficiency anemia (IDA) and anemia of inflammation (AI), the major causes of anemia, remains a challenge and novel biomarkers are needed. This prospective study characterizes metabolomic changes in patients with anemia, compares IDA and AI, and evaluates the ability of metabolomic profiling to categorize otherwise unclassifiable anemia (UA) cases. Methods: In the single-center cross-sectional study, patients with anemia were classified as IDA, AI, or their combination (IDA + AI) according to traditional iron biomarkers. Targeted metabolomic analysis was conducted with tandem mass spectrometry using the MxP^® Quant 500 kit, with 617 individual metabolites and 227 calculated parameters in the final analysis. Results: The final cohort included 70 patients with anemia and 27 controls. The concentrations of six metabolites and six calculated parameters were significantly different in patients with anemia compared to controls. Anemia was associated with decreased concentrations of several polyunsaturated fatty acid (PUFA)-containing triglycerides (n = 3) and phosphatidylcholines (n = 2), as well as with increased asparagine/aspartate and docosahexaenoic acid/eicosapentaenoic acid ratio. Multivariate analysis using only metabolomic data differentiated between IDA and AI with a general classification accuracy of 88%. Unclassifiable anemia samples were reclassified mostly as IDA (n = 11) or IDA + AI (n = 6), with one sample reclassified as AI. Conclusions: Metabolomic markers of PUFAs differ between patients with anemia and controls, indicating possible alterations in lipid metabolism. Our preliminary findings suggest that metabolomic data may be capable of distinguishing between IDA and AI. However, owing to several limitations of the current study, the potential utility of metabolome-based approaches should be confirmed in independent validation studies. Full article

Neuropathic pain (NP) arises from diverse conditions, including peripheral nerve injury, spinal cord injury (SCI), and painful diabetic neuropathy, yet these disorders share oxidative stress, mitochondrial dysfunction, lipid dysregulation, and altered neuronal excitability. We investigated whether dietary omega-3 polyunsaturated fatty acids modulate ferroptotic stress-associated pathways, defined as lipid peroxidation susceptibility and impaired antioxidant defense rather than overt ferroptotic cell death. Female Sprague–Dawley rats received either a soy oil control diet (SOD) or fish oil omega-3-enriched diet (FOD) before chronic constriction injury (CCI). Behavioral outcomes were assessed using Hargreaves and CatWalk testing, followed by dorsal root ganglion (DRG) RNA sequencing, RT-PCR, and GPX4 ELISA. Previously generated SCI metabolomics and human diabetic serum metabolomic/lipidomic datasets were re-analyzed for shared pathways. FOD attenuated CCI-induced thermal hypersensitivity and improved gait parameters. DRG transcriptomics showed reduced injury-associated transcriptional disruption, enrichment of selenoamino acid metabolism, nonsense-mediated decay, and ribosomal quality-control pathways, and reduced mitochondrial dysfunction pathway activity. Omega-3 increased Gpx1/Gpx4 expression and GPX4 protein, reduced pain-associated genes including Scn10a, Piezo2, Trpa1, and Oprm1, and aligned with selenoamino acid enrichment in SCI and human datasets. Human lipidomics showed MG/DG/PC/PE pathway remodeling. These findings support ferroptotic stress as a plausible shared downstream mechanism modulated by omega-3 supplementation across NP models. Full article

This study evaluates the effects of seven biochemical stimulants, ferulic acid, malic acid, L-carnitine, ergothioneine, magnesium sulfate, trehalose, and betaine, on biomass accumulation, total lipid content, and docosahexaenoic acid (DHA) production in Aurantiochytrium sp. ATCC PRA-276 under controlled fermentation conditions. The compounds were selected based on their reported roles in antioxidant defense, carbon flux regulation, osmoprotection, or methyl group donation, with the aim of assessing whether targeted, non-GMO supplementation could modestly enhance microbial productivity. Compared with the control, supplementation with L-carnitine and ferulic acid resulted in the greatest enhancement of DHA production, increasing DHA concentration by 31.7% and 29.2%, respectively. These treatments were also associated with statistically significant, albeit moderate, increases in total lipid accumulation and biomass production. These responses indicate correlated improvements in overall cellular productivity rather than isolated effects on lipid biosynthesis. DHA concentrations were quantified following lipid extraction and transesterification using GC-based analysis; however, comprehensive fatty acid compositional profiling (e.g., saturated, monounsaturated, and polyunsaturated fatty acid distributions or DHA-to-total lipid ratios) was not performed. Although direct mechanistic assays were not performed, the observed trends are consistent with known biochemical functions related to redox balance, cofactor availability, and stress adaptation. A preliminary cost-efficiency analysis identified malic acid as the most economical stimulant for DHA enhancement, whereas ergothioneine was the least cost-effective despite measurable biological effects. Collectively, these findings demonstrate that biochemical stimulation can provide incremental yet reproducible gains in DHA production and lipid accumulation. This work supports the use of targeted biochemical supplementation as a scalable, non-GMO strategy for microbial omega-3 production and establishes a foundation for future optimization through combinatorial supplementation, multi-omics validation, and process engineering. Full article

Production system may affect meat quality and muscle metabolic characteristics in Tibetan sheep. In this study, the biceps femoris muscles of twelve 3-year-old Tibetan sheep with similar body weights were used as experimental materials during a 6-month experimental period. The housed group (n = 6) was defined as the control group (C group), whereas the grazing group (n = 6) was defined as the L group. Meat quality measurement, nutritional composition analysis, untargeted lipidomics, and amino acid metabolomics (AAM) were integrated to investigate the effects of contrasting grazing and house-feeding production systems on meat quality and metabolic characteristics in Tibetan sheep. The results showed that cooking loss and drip loss were significantly decreased, whereas water-holding capacity (WHC) was significantly increased in the L group. However, shear force was also increased, indicating that grazing and house-feeding systems were associated with differences in muscle WHC and shear force. The L group exhibited significant alterations in lipid composition and increased concentrations of several n-3 polyunsaturated fatty acids and increased levels of omega-3 polyunsaturated fatty acids (n-3 PUFAs), including α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), suggesting that grazing and house-feeding systems were associated with differences in the lipid nutritional profile of muscle. Lipidomic analysis showed that the differential lipids were mainly enriched in triacylglycerols (TGs), phosphatidylethanolamines (PEs), and phosphatidylcholines (PCs), and several PUFA-containing TGs and membrane lipid molecules were closely associated with meat quality traits. AAM analysis showed that branched-chain amino acids (BCAAs), including L-leucine and L-valine, as well as N,N-dimethylglycine, were upregulated in the L group, whereas kynurenine and 1-methyl-L-histidine were downregulated. These findings suggest that BCAA metabolism and tryptophan–kynurenine metabolism were associated with metabolic differences observed between production systems in muscle metabolic adaptation. However, amino acid metabolomics analysis revealed that no amino acid metabolites remained significant after FDR correction, and thus the observed pathway-level changes (e.g., BCAA metabolism and tryptophan–kynurenine pathway) should be interpreted as nominal and exploratory findings. Overall, the results indicate that feeding systems were associated with alterations in the lipid and amino acid metabolic profiles of the biceps femoris muscle in Tibetan sheep, which were further associated with differences in muscle WHC, shear force, lipid nutritional composition, and the profile of flavor precursors. This study provides a theoretical basis for optimizing plateau meat sheep production systems and developing high-quality Tibetan sheep meat products. Full article

Oocyte quality determines fertilization success during the reproductive period of fish and is affected by a key intrinsic factor: the level of lipid deposition in the yolk. In this study, lipidomics was used to characterize lipid profiles of adipose tissue, liver, serum and ovary to clarify divergent hepatic lipid allocation to fat depots versus ovary in Sichuan taimen (Hucho bleekeri). The results showed that glycerophospholipids (GPs) constituted the most diverse lipid class across all four tissues, with phosphatidylcholine (PC) being the most abundant in each tissue. Relative to adipose tissue, liver, and serum, the ovary exhibited significant enrichment of PC and phosphatidylethanolamine (PE) and higher accumulation of docosahexaenoic acid (DHA)- and arachidonic acid (ARA)-containing GPs and triacylglycerols (TGs), as well as enrichment in TGs, diacylglycerols (DGs), and cardiolipin (CL), compared to adipose tissue. The expression levels of fads6, elovl2, elovl5, dgat1b, dgat2, pparα, nfyb, and fabp7 were higher in the liver, while lpcat1 was highly expressed specifically in the ovary. The results of this study demonstrate that long-chain polyunsaturated fatty acids (LC-PUFAs) exhibited selective enrichment in the ovary, which facilitates yolk lipid deposition and provides structural and energetic support for oocyte development and early embryonic development. From a lipidomic perspective, this study reveals the regulatory characteristics underlying ovarian yolk deposition in H. bleekeri, providing important evidence for understanding the mechanisms of egg quality formation as well as a theoretical basis for broodstock management, artificial propagation, and the improvement of egg and larval quality. Full article

Rice–crayfish co-culture is a dominant aquaculture mode in China, while the regional heterogeneity in crayfish nutritional quality remains insufficiently clarified. This study collected rice-field-cultured crayfish samples from six major producing provinces (Henan, Hubei, Hunan, Jiangxi, Jiangsu, and Anhui) to systematically evaluate their meat yield, conventional nutritional components, amino acid and fatty acid profiles, and mineral element contents. Significant regional differences were observed in all measured indicators. Jiangsu crayfish showed the highest meat yield (22.97% in females, 20.72% in males), crude protein (18.5%), and total amino acids (16.59 g/100 g). Jiangxi samples had the highest crude fat (0.7%), ash (1.5%), and calcium (1280 mg/kg). Anhui crayfish exhibited the highest polyunsaturated fatty acid (PUFA) content (47.30%). Hubei recorded the highest total eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) (22.41%). Henan crayfish were highest in EPA (19.6%) and manganese (3.72 mg/kg), while Hunan samples had the highest iron (9.06 mg/kg). Valine was identified as the first limiting amino acid in all provinces, with secondary limiting amino acids varying regionally. Despite regional differences in specific nutritional indices, crayfish from all six provinces consistently exhibited high protein, low fat, balanced amino acid profiles, abundant unsaturated fatty acids, and rich essential minerals, with all measured nutritional mineral contents within national food safety limits. The findings provided empirical data and a scientific basis for crayfish quality evaluation, origin characteristic analysis, and targeted nutritional optimization of farming formulas, as well as for the differentiated development of regional crayfish industries. Full article

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by amyloid-β (Aβ) deposition, tau hyperphosphorylation, neuroinflammation, mitochondrial dysfunction, and oxidative stress. Despite recent advances, current therapies offer little benefit, and AD remains a significant challenge. Polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have attracted attention for their neuroprotective effects primarily through anti-inflammatory and antioxidant properties, but also for their ability to influence membrane fluidity and neuronal function. DHA is the predominant omega-3 PUFA in nerve cell membranes and is critical for synaptic plasticity and cognitive function. Some evidence has demonstrated that marine omega-3 supplementation reduces Aβ deposition, modulates microglial activation, and prevents cognitive decline in animal models. Even with heterogeneous results, preclinical and clinical studies suggest that long-term DHA/EPA supplementation can improve cognitive function in subjects with mild cognitive impairment (MCI) and reduce neuroinflammation markers. However, individual variability and brain bioavailability pose significant challenges. This review summarizes and discusses the current knowledge on the importance of PUFAs for human health, exploring novel mechanistic hypotheses, such as the effect of omega-3 fatty acids on brain iron homeostasis, the microbiota–gut–brain axis, the glymphatic system, and miRNAs. Furthermore, it focuses on the therapeutic potential of PUFAs in the treatment of AD and proposes future directions for translational research. Full article

Background: Type 2 inflammatory diseases are among the most common chronic inflammatory conditions in childhood and represent a growing global health burden. Increasing evidence suggests that early-life nutritional exposures may influence immune programming and allergic disease development. This Position Paper aims to summarize the current evidence regarding the immunomodulatory role of polyunsaturated fatty acids (PUFAs), particularly omega-3 long-chain fatty acids, in the prevention of allergic diseases during early life. Methods: A scoping literature review and consensus process were conducted to map biological mechanisms and clinical evidence linking omega-3 PUFAs with allergic disease prevention. This document analyzed experimental, observational, and randomized controlled studies evaluating maternal prenatal/lactational omega-3 exposure. The clinical evidence was qualitatively appraised using study-design-specific Joanna Briggs Institute (JBI) Critical Appraisal Tools. Particular attention was given to immune modulation, inflammatory pathways, epithelial barrier function, gut microbiota interactions, and the ferroptosis–immune–metabolic axis. Results: Omega-3 PUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), exert immunomodulatory and anti-inflammatory effects through multiple mechanisms, including specialized pro-resolving mediator production, regulation of T-helper cell responses, cytokine modulation, maintenance of epithelial barrier integrity, and microbiota interaction. Emerging evidence also supports their involvement in oxidative stress and ferroptosis regulation. Current clinical evidence, particularly from higher-quality prenatal randomized trials and evidence syntheses, suggests that adequate maternal omega-3 intake during pregnancy and lactation may reduce the risk of respiratory allergic outcomes, especially wheezing and asthma, in selected offspring. Conclusions: Adequate omega-3 PUFA intake, such as 2 g/die, during critical windows of immune maturation may represent a valuable strategy for the primary prevention of allergic diseases. Current evidence most strongly supports supplementation during pregnancy and lactation, particularly in populations with low dietary omega-3 intake or increased allergic risk. Omega-3 supplementation should be considered within a broader multifactorial preventive approach aimed at promoting immune tolerance and reducing the future burden of allergic diseases. Full article

Background/Objectives: Dietary fish oil supplementation has been associated with lower total plasma triacylglycerols in felines. The present study aimed to characterize this effect in more detail, using lipidomic analyses. Methods: Plasma samples of cats (n = 10), receiving a complete basic diet, with and without the addition of 0.5 g and 1.0 g fish oil/kg body weight/day, each for 21 days, in a randomized crossover design, were analyzed by an FIA MS/MS-based targeted metabolomics approach. Results: The results demonstrated that 360 metabolites were affected by the dietary treatments, predominantly belonging to triacylglycerols (n = 124), phosphatidylcholines (n = 68), phosphatidylethanolamines (n = 63), phosphatidylglycerols (n = 33), and phosphatidylinositols (n = 21). Lowering effects of fish oil supplementation on plasma triacylglycerols could be confirmed. However, increased levels of specific triacylglycerols were also observed, especially of those containing eicosapentaenoic or docosahexaenoic acid. The decreased triacylglycerols showed a lower number of carbons and a lower degree of unsaturation than the enhanced triacylglycerols. Such a lipid profile is assumed to be beneficial in human medicine; its relevance for feline health, however, is unclear so far. Conclusions: In conclusion, the lipidomic analyses provided a detailed characterization of the feline plasma lipidome and its modulation by a dietary fish oil supplementation. The clinical relevance of these findings warrants further investigation. Full article

Photoreceptor (PR) degeneration is a shared pathological feature of multiple blinding retinal diseases. This narrative review examines the mechanisms underlying PR vulnerability to ferroptosis-associated lipid-peroxidation injury, with emphasis on three interconnected features: the marked enrichment of docosahexaenoic acid (DHA) and other polyunsaturated fatty acids (PUFAs) in PR outer-segment disc membranes; the chronically high metabolic demand of PRs and the specialized spatial organization of their mitochondria; and retinal pigment epithelium (RPE)–PR metabolic coupling, including outer-segment renewal and phagocytic turnover, glucose transport and lactate shuttling, and visual-cycle–related all-trans-retinal (atRAL) clearance and bisretinoid accumulation. We also summarize antioxidant defense systems centered on the cystine/glutamate antiporter (xCT)–glutathione (GSH)–glutathione peroxidase 4 (GPX4) axis and mitochondrial GPX4 (mtGPX4), which restricts iron-dependent lipid peroxidation in PRs. We propose that highly oxidizable membrane phospholipid substrates, mitochondrial homeostatic imbalance, and impaired RPE–PR metabolic coupling may collectively shape PR susceptibility to ferroptosis-associated injury. From a therapeutic perspective, this framework supports multitarget strategies designed to interrupt lipid-peroxidation propagation, stabilize mitochondrial redox homeostasis and quality-control mechanisms, and restore RPE–PR metabolic support and local iron-buffering capacity. Full article

Adolescence is a developmental stage marked by dynamic interactions between diet, the gut microbiome and endocrine maturation, creating a physiological environment in which early metabolic disturbances can rapidly translate into long-term cardiovascular vulnerability. This narrative review summarises the latest research on the diet–microbiome–hormone axis in adolescents, focusing on the metabolic pathways through which microbial metabolites influence host physiology. Short-chain fatty acids (SCFAs), microbially transformed bile acids and postbiotic signalling molecules regulate enteroendocrine communication, insulin sensitivity, vascular function and inflammatory tone, thereby linking dietary exposures to early cardiometabolic alterations. Dysbiosis, driven by ultra-processed dietary patterns, low fibre intake and reduced microbial diversity, promotes metabolic endotoxemia, neuroendocrine imbalance and endothelial impairment, all of which are recognised as early indicators of cardiovascular disease. A distinctive contribution of this review is the integration of PF into the adolescent cardiometabolic framework. This emerging biotechnological process enables the controlled production of structurally defined bioactive compounds, including angiotensin-converting enzyme (ACE) inhibitory peptides, targeted prebiotic oligosaccharides, fermentable substrates that promote SCFA formation, microbially derived eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), phytosterols and purified postbiotics. These compounds modulate several regulatory pathways, such as the renin–angiotensin–aldosterone system, lipid and bile acid metabolism, gut barrier stability, inflammatory signalling and endocrine axes involving glucagon-like peptide-1 (GLP-1), peptide YY (PYY), leptin, insulin sensitivity and growth hormone/insulin-like growth factor-1 (GH/IGF-1) dynamics. By situating precision fermentation within the broader context of adolescent metabolic susceptibility, this review highlights its potential to support microbiome resilience, stabilise hormonal regulation and mitigate early cardiovascular risk. However, further adolescent-specific clinical trials and long-term safety assessments are required to translate these advances into effective public health strategies. Full article

Canned fish products enable long-term preservation of fish, a vital source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Despite research on lipid composition, gaps remain in understanding the bidirectional fatty acid (FA) exchange between fish muscle and coating media during processing and storage. After a systematic literature search across five databases (PubMed, Scopus, Web of Science, Wiley Online Library, Cochrane Library), 20 studies were included examining FA profiles across fish species, filling media (vegetable oils, brine, tomato sauce), and storage durations (up to 5 years). Five studies showed that n-3 FAs migrate from fish to the filling medium, enhancing its nutritional value, while fish muscle absorbs FAs from the oil, increasingly resembling the filling medium. The use of n-6 FA-rich oils (sunflower, soybean) lowered the n-3/n-6 ratio in flesh. Conversely, aqueous media (brine) and tomato sauce maintained better ratios. EPA and DHA content generally decreased due to canning and storage, with retention varying by fish species, filling medium, and sterilization method. This review underscores significant FA exchange between fish and filling media, confirming bidirectional lipid interchange during processing. To optimize health benefits, aqueous packing media are recommended to preserve lipid profiles or to consume the covering oil to recover nutrients. Further research is needed on other factors altering FA content in canned fish such as environmental and geographical variables (including catching season), pre-canning preparation and sterilization steps (such as freezing, steaming, and frying), sterilization conditions (time, temperature, F₀ value) and lipid oxidation induced by thermal processing. Full article

Background/Objectives: Excitotoxicity, primarily caused by excessive glutamate signaling, is a significant contributor to the aetiology of several neurological disorders. Docosahexaenoic acid (DHA), a long-chain omega-3 polyunsaturated fatty acid, is known for its neuroprotective properties, including antioxidants and anti-inflammatory effects. However, the existing literature has not sufficiently reviewed its specific role in glutamate-induced excitotoxicity. This systematic review aimed to provide comprehensive information from the literature on the neuroprotective effects of DHA in models of glutamate-induced neurotoxicity. Methods: A systematic search was conducted in the Cochrane Library, Scopus, Web of Science, PubMed, ScienceDirect, and Google Scholar, following PRISMA 2020 guidelines. The following keywords were used: DHA OR docosahexaenoic acid AND excitotoxicity OR glutamate-induced excitotoxicity OR glutamate-induced neurotoxicity. A total of 475 articles were screened, and 13 original articles published between 2003 and 2025 were included for data extraction. These studies included nine in vivo animal studies, three ex vivo studies, and one in vitro study. The risk of bias was assessed using SYRCLE’s methodology. Results: Our findings demonstrate that DHA provides substantial neuroprotection against excitotoxicity through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms. Furthermore, DHA enhances neuronal function and cognitive performance by modulating neurotransmitter levels and glutamate-related signaling pathways. Despite these positive outcomes, heterogeneity across studies suggests that the neuroprotective properties of DHA may be affected by various parameters, such as the source of DHA, treatment dose and duration, age and experimental design. Conclusions: Although previous studies have demonstrated the benefits of DHA in preclinical and clinical settings of neurological disorders, further clinical studies focusing on the modulation of excitotoxicity by DHA are needed to validate its translational efficacy and therapeutic significance. Full article